Gutierrez-Bautista, Juan FranciscoMartinez-Chamorro, AlbaRodriguez-Nicolas, AntonioRosales-Castillo, AntonioJimenez, PilarAnderson, PerLopez-Ruz, Miguel AngelLopez-Nevot, Miguel AngelRuiz-Cabello, Francisco2023-05-032023-05-032022-06-22Gutiérrez-Bautista JF, Martinez-Chamorro A, Rodriguez-Nicolas A, Rosales-Castillo A, Jiménez P, Anderson P, et al. Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients. Int J Mol Sci. 2022 Jun 23;23(13):6979.http://hdl.handle.net/10668/21168The SARS-CoV-2 disease presents different phenotypes of severity. Comorbidities, age, and being overweight are well established risk factors for severe disease. However, innate immunity plays a key role in the early control of viral infections and may condition the gravity of COVID-19. Natural Killer (NK) cells are part of innate immunity and are important in the control of virus infection by killing infected cells and participating in the development of adaptive immunity. Therefore, we studied the short tandem repeat (STR) transmembrane polymorphisms of the major histocompatibility complex class I chain-related A (MICA), an NKG2D ligand that induces activation of NK cells, among other cells. We compared the alleles and genotypes of MICA in COVID-19 patients versus healthy controls and analyzed their relation to disease severity. Our results indicate that the MICA*A9 allele is related to infection as well as to symptomatic disease but not to severe disease. The MICA*A9 allele may be a risk factor for SARS-CoV-2 infection and symptomatic disease.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/MICAMICA STR polymorphismsNK cellsSARS-CoV-2innate immunityCOVID-19Histocompatibility Antigens Class IHumansMajor Histocompatibility ComplexPolymorphism, GeneticSARS-CoV-2research article35805975open accessAntígenos de histocompatibilidad Clase IComplejo mayor de histocompatibilidadPolimorfismo genéticoSARS-CoV-210.3390/ijms231369791422-0067PMC9266713https://www.mdpi.com/1422-0067/23/13/6979/pdf?version=1656157840https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266713/pdf